A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Summary

The main purpose of this study to evaluate the safety and tolerability of CNTO 2476 administered subretinally (beneath the retina) using the iTrack Model 275 micro catheter in patients with visual acuity (acuteness or clearness of vision) impairment associated with the geographic atrophy (GA: partial or complete wasting away of retinal layer below the retina) manifestation of age-related macular degeneration (AMD: medical condition which usually affects older adults and results in a loss of vision in the center of the visual field \[the macula\] because of damage to the retina).

Timeline

Start

2010-10-21

Primary completion

2015-03-31

Completion

2017-05-31

Drugs

Indications